The independent source for health policy research, polling, and news.
4,161 - 4,180 of 15,457 Results
The little-used Congressional Review Act allows a new administration and Congress to fast-track the repeal of regulations and other executive actions of the previous administration. But neither lawmakers nor the president are making any attempt to use it now.
Same building. Same procedure. Same doctor. But now you’re charged a hospital facility fee. For one Ohio Medicare patient, the copay for a shot that used to cost her about $30 went up to more than $300.
A Texas federal judge, who previously ruled the Affordable Care Act unconstitutional, has signaled his openness to ending the law’s popular coverage requirement for preventive services.
In his campaign, President Joe Biden promised to undo policies, particularly health policies, implemented by former President Donald Trump. Yet, despite immense executive power, reversing four years of action takes time and resources.
After a bruising confirmation process, Xavier Becerra was sworn in as secretary of Health and Human Services this week. The Senate also confirmed the nominations of former U.S. Surgeon General Vivek Murthy to return to the post he held in the Obama administration, and former Pennsylvania health secretary Rachel Levine as assistant secretary for health. Levine is the first openly transgender person to receive Senate confirmation. Meanwhile, questions continue to swirl around the AstraZeneca covid vaccine, which some public health experts worry will create more hesitancy toward other vaccines.
Clinicians at pediatric hospitals are experimenting with “smell training” among children who had covid-19 and have now lost this sense.
Many inmates at Western Missouri Correctional Center, like their peers in prisons across Missouri and the nation, are hesitant about getting vaccinated against covid-19 because they don’t trust prison health care.
The Tuskegee syphilis study is often cited as a reason Black Americans might hesitate to take the covid-19 vaccine. But many people say that current racism in health care and lack of access deserve more attention to move more Black Americans toward vaccine protection.
The $1.9 trillion covid relief bill expands subsidies for private insurance plans. That will lighten the burden on consumers, but it locks taxpayers into yet more support for the health care industry.
Air-cleaning companies with limited oversight are targeting a growing market of schools desperate for covid-19 protection. Donald Trump’s former covid adviser lands with one that built its business, in part, on ozone-emitting technology.
Democrats’ $1.9 trillion covid relief package will offer some of the most significant help for Americans to pay for health insurance in a decade. But the temporary provisions are complicated. KHN offers tips for consumers.
Covid vaccinations are ramping up, so “An Arm and a Leg” checked in on the effort in Philadelphia, where capitalism and compassion have clashed.
Many students at Sarah Scott Middle School in Terre Haute, Indiana, deal with poverty, dysfunction and stress. Since the pandemic hit, teachers and administrators have struggled to give kids and families the support they need.
In Virginia, if you called 1-877-VAX-IN-VA to register for a vaccine and wanted help in a language other than English or Spanish, the system might hang up on you.
A Trump administration Medicare rule will push some hospital patients into a Catch-22: The government says several hundred procedures no longer need to be done in a hospital, but it did not approve them to be performed elsewhere. So patients will still need to use a hospital while not officially admitted — and may be charged more out-of-pocket for the care.
Progressive and conservative Democratic lawmakers, as well as President Joe Biden, are in favor of authorizing federal officials to negotiate with drugmakers over what Medicare pays for at least some of the most expensive brand-name drugs and to base those prices on the drugs’ clinical benefits. Such a measure could put Republicans in the uncomfortable position of opposing an idea that most voters from both parties generally support.
The once-promising therapy that infuses blood plasma from recovered covid-19 patients into newly infected people, theoretically to boost immunity, has suffered setbacks. But some proponents say it’s too early to abandon the treatment.
It’s the second spring break of the pandemic, and rumors abound about people exploiting loopholes to get vaccinated in order to party. But some students who’ve been immunized were eligible because of where they work or underlying health conditions.
Across the country, a mishmash of rules to qualify for a precious covid shot is creating nightmares for consumers. Criteria including age, occupation and medical conditions vary dramatically.
The vaccination rollout has been unsteady, but the vaccines seem very effective, raising hopes that the pandemic will subside by later this year if enough Americans get their shots. Meanwhile, remain cautious.
© 2026 KFF